The latest market price trends of imported dasatinib in 2025

Dasatinib (Dasatinib) is a second-generation BCR-ABL tyrosine kinase inhibitor commonly used in the treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). The drug has been officially launched in China for many years and has been included in the national medical insurance catalog. Patients can purchase medicines through prescriptions issued by regular hospitals, and enjoy a certain percentage of cost reimbursement according to local medical insurance policies. However, the out-of-pocket amount after medical insurance reimbursement may still be high, and patients are advised to consult the pharmacy of the hospital in their area for specific consultation.

Despite being covered by medical insurance, the price of dasatinib’s original drug (trade nameSprycel) is still high. According to market knowledge, common specifications such as 50mg or 100mg tablets are priced at several thousand yuan per box, depending on the hospital, dosage and length of treatment. The cost of a month's treatment, even after reimbursement by medical insurance, may still require patients to bear out-of-pocket expenses of more than 1,000 yuan, and the financial burden is still heavy for some patients.

In order to reduce financial pressure, many patients will pay attention to overseas generic versions of drugs. At present, two pharmaceutical companies in India, Mylan and NATCO, have launched generic versions of dasatinib. The ingredients are the same as the original drug and the price is more advantageous. Common specifications such as 50mg 60 tablets or 100mg 30 tablets are sold for about five to six hundred yuan per box, which is significantly lower than the original drug. Generic drugs have been legally sold in India and exported to many countries and regions through formal channels.

For patients who cannot afford the cost of original drugs, Indian generic drugs are undoubtedly a more economical option. However, it should be noted that patients should obtain it through formal purchasing channels or international medical institutions to avoid affecting the efficacy or safety of drugs due to unknown sources. At the same time, dasatinib should be used strictly under the guidance of a doctor, and the dosage form or dosage should not be changed at will. Regardless of whether you choose original drugs or generic drugs, standardized treatment and regular review are the key to ensuring the therapeutic effect.

xa0